End Taxpayer Funding of Gender Experimentation Act of 2025

Bill 119 HR 2202, also known as the "Prohibit Taxpayer-Funded Gender Transition Procedures Act," aims to prevent taxpayer dollars from being used to fund gender transition procedures. The bill specifically targets procedures such as hormone therapy and gender reassignment surgery.

The bill states that federal funds should not be used to cover the costs of these procedures, arguing that they are not medically necessary and should not be funded by taxpayers. Supporters of the bill argue that it is unfair for taxpayers to foot the bill for procedures that they may not agree with or support.

Opponents of the bill argue that denying access to gender transition procedures can have negative impacts on the mental health and well-being of transgender individuals. They argue that these procedures are essential for transgender individuals to live authentically and should be covered by insurance, including government-funded programs. Overall, the bill is a controversial and divisive issue, with strong opinions on both sides. It is currently being debated in Congress, and its outcome remains uncertain.